Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Science (New York, N.Y.)|December 2, 1977
Saccharin and other sweeteners: mutagenic propertiesR P Batzinger, S Y Ou, E BuedingCancer Research|December 1, 1978
Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agentsR P Batzinger, S Y Ou, E BuedingThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1977
Mutagenic activities in vitro and in vivo of five antischistosomal compoundsR P Batzinger, E BuedingHepatology (Baltimore, Md.)|January 1, 1981
Protection by antibiotics against experimental focal cholangitis produced in mice by a schistosomicidal isothiocyanateR P Batzinger, E Bueding, H PopperJournal of Medicinal Chemistry|July 1, 1977
Differences in antischistosomal and mutagenic properties between an isothiocyano- and an isocyanonitrodiphenylamineA W Coulter, E Bueding, R P BatzingerEnvironmental Mutagenesis|January 1, 1979
Prevention of the mutagenic activation of an antischistosomal isothiocyanate in primates by an antibioticR P Batzinger, E Bueding, K Crawford, et al.Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1980
Mutagenic activation of an antischistosomal drug by enteric Streptococcus sps in vitro and in vivoC J Molineaux, R P Batzinger, W Schmidt, et al.Antimicrobial Agents and Chemotherapy|October 1, 1982
Conversion of amoscanate to a mutagenic metabolite in gnotobiotic mice implanted with Streptococcus equinusB S Reddy, R P Batzinger, C J Molineaux, et al.Cancer Research|March 1, 1978
Formation of a mutagenic drug metabolite by intestinal microorganismsR P Batzinger, E Bueding, B S Reddy, et al.Mutation Research|January 1, 1977
Mutation induction by the antischistosomal drug F30066 in various test systemsT M Ong, D F Callen, S L Huang, et al.Pageof 6